Abstract
Background In recent years, the implementation of artificial intelligence (AI) in healthcare is progressively transforming medical fields, with Clinical Decision Support Systems (CDSS) as a notable application. Laboratory tests are vital for accurate diagnoses, but their increasing reliance presents challenges. The need for effective strategies for managing laboratory test interpretation is evident from the millions of monthly searches on test results’ significance. The potential role of CDSS in laboratory diagnostics gains significance, however, more research needs to explore this area.
Objective The primary objective of our study was to assess the accuracy and safety of LabTest Checker (LTC), a CDSS designed to support medical diagnoses by analyzing both laboratory test results and patients’ medical histories
Methods This cohort study embraced a prospective data collection approach. A total of 101 patients were enrolled, aged 18 and above, in stable condition, requiring comprehensive diagnosis. A panel of blood laboratory tests was conducted for each participant. Participants utilized LabTest Checker for test result interpretation. Accuracy and safety of the tool were assessed by comparing AI-generated suggestions to experienced doctor (consultant) recommendations, considered the gold standard.
Results The system achieved a 74.3% accuracy and 100% sensitivity for emergency safety and 92.3% sensitivity for urgent cases. It potentially reduced unnecessary medical visits by 41.6% and achieved an 82.9% accuracy in identifying underlying pathologies.
Conclusion This study underscores the transformative potential of AI-based CDSS in laboratory diagnostics, contributing to enhanced patient care, efficient healthcare systems, and improved medical outcomes. LabTest Checker’s performance evaluation highlights the advancements in AI’s role in laboratory medicine.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT05813938
Funding Statement
This research was funded by the National Center for Research and Development under submeasure 1.1.1 Industrial Research and Development Works, the Intelligent Development Operational Program 2014-2020, Co-financing Agreement No. POIR.01.01.01-00-0297/19-00 of 13 November 2019
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Bioethics Committee of the Medical University of Silesia (Approval Code: PCN/CBN/0052/KB1/115/I/22, Approval Date: 08.11.2022)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
